ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on Twitter

Kidney Week

Abstract: FR-PO351

Class IIa Histone Deacetylase Inhibition Suppresses Renal Fibroblast Activation and Lessens Fibrosis

Session Information

Category: Chronic Kidney Disease (Non-Dialysis)

  • 308 CKD: Mechanisms of Tubulointerstitial Fibrosis

Authors

  • Xiong, Chongxiang, Rhode Island Hospital, Providence, Rhode Island, United States
  • Zhuang, Shougang, Rhode Island Hospital, Alpert Medical School of Brown University, Providence, United States
Background

Histone deacetylases (HDACs) are a family of enzymes involved in regulation of cellular functions, including proliferation, migration and survival. Class I and III HDACs are associated with renal fibrosis. The role of class II HDAC in this process is poorly understood.

Methods

We examined the role of class IIa HDACs (HDAC- 4, -5, -7, -9) in renal fibroblast activation and fibrosis using MC1568, a highly selective class IIa HDAC inhibitor, and the siRNA specifically targeting individual class IIa HDACs.

Results

Exposing cultured renal interstitial fibroblasts to MC1568, or silencing class IIa HDAC-4 and-7, significantly reduced activation as indicated by decreased a-smooth muscle actin, collagen 1 and fibronectin expression. In a murine model of renal fibrosis induced by unilateral ureteral obstruction (UUO), HDAC-4 was highly expressed whereas expression levels of HDAC-5, -7, -9 were only slightly elevated. MC1568 suppressed deposition of extracellular matrix proteins and renal fibroblast activation. This coincided with reduced numbers of renal epithelial cells arrested at G2/M cell cycle phase and restored expression of Klotho and BMP7 after UUO injury. MC1568 also abrogated UUO-induced phosphorylation of receptor tyrosine kinases (epidermal growth factor and platelet growth factor receptors) and several signaling molecules associated with renal fibrosis, including Smad-3, STAT3, and NF-κB and ERK1/2. Moreover, class IIa inhibition suppressed renal expression of HIF-1α, Notch-1 and -3 and preserved expression of PPAR-alpha and PPAR-gama following UUO.

Conclusion

Class IIa HDACs inhibition may attenuate renal fibrosis by inhibiting profibrotic signaling pathways and preserving expression of renoprotective factors.

Funding

  • NIDDK Support